<DOC>
<DOCNO>
EP-0001443
</DOCNO>
<TEXT>
<DATE>
19790418
</DATE>
<IPC-CLASSIFICATIONS>
A61K-38/16 C07K-14/435 C07K-14/47 C07G-7/00 A61K-39/00 A61K-35/50 A61K-38/00 A61K-35/48 <main>A61K-37/02</main> C07K-16/18 
</IPC-CLASSIFICATIONS>
<TITLE>
agent for the contraception and termination of pregnancy and process for its production.
</TITLE>
<APPLICANT>
behringwerke agde<sep>behringwerke aktiengesellschaft<sep>behringwerke aktiengesellschaftpostfach 114035001 marburgde<sep>behringwerke aktiengesellschaft<sep>
</APPLICANT>
<INVENTOR>
bohn hans dr<sep>weinmann ernst dr<sep>bohn, hans, dr.<sep>weinmann, ernst, dr.<sep>bohn, hans, dr.oberer eichweg 26d-3550 marburg/lahnde<sep>weinmann, ernst, dr.sonnenweg 19d-3550 marburg/lahnde<sep>bohn, hans, dr.<sep>weinmann, ernst, dr.<sep>bohn, hans, dr.oberer eichweg 26d-3550 marburg/lahnde<sep>weinmann, ernst, dr.sonnenweg 19d-3550 marburg/lahnde<sep>
</INVENTOR>
<ABSTRACT>
Means for conceptual prevention and pregnant business interruption at primates, characterized in that it contains an effective amount of a substance which can react immunologically with the protein PP₅ in parenteral administration or immunologically reactive substances directed against the PP₅.
</ABSTRACT>
</TEXT>
</DOC>
